Nicolas Boyer

Nicolas BOYER, Ph.D., is a highly experienced Principal Scientist at Merck since July 2017, previously serving as Associate Principal Scientist in the Boston Discovery Chemistry department. Expertise includes designing novel modalities, particularly macrocyclic peptides for oncology and immunology, alongside automated peptide synthesis. Prior experience at IPSEN Bioscience involved optimizing peptides for medicinal chemistry programs in endocrinology and oncology. Nicolas BOYER's background includes roles at Ra Pharmaceuticals, MIT, and Université de Montréal, focusing on peptide and peptidomimetic synthesis, total synthesis of natural products, and innovative drug design. Academic credentials include a Ph.D. in Organic Chemistry from the Institut National des Sciences Appliquées de Rouen and multiple degrees in chemistry and chemical engineering.